Ion Beam Applications SA (IBAB.BR)
EUR 12.62
(-2.17%)
EUR 12.62
(-2.17%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 7.11 Million EUR | -33.18% |
| 2022 | 10.64 Million EUR | -64.44% |
| 2021 | 29.93 Million EUR | -27.29% |
| 2020 | 41.17 Million EUR | 25.32% |
| 2019 | 32.85 Million EUR | 8.11% |
| 2018 | 30.39 Million EUR | 57.58% |
| 2017 | 19.28 Million EUR | -30.5% |
| 2016 | 27.75 Million EUR | 85.0% |
| 2015 | 15 Million EUR | -42.86% |
| 2014 | 26.25 Million EUR | -36.36% |
| 2013 | 41.25 Million EUR | 12.05% |
| 2012 | 36.81 Million EUR | 57.72% |
| 2011 | 23.34 Million EUR | -42.06% |
| 2010 | 40.28 Million EUR | 532.25% |
| 2009 | 6.37 Million EUR | -46.39% |
| 2008 | 11.88 Million EUR | -33.43% |
| 2007 | 17.85 Million EUR | -1.66% |
| 2006 | 18.15 Million EUR | -6.2% |
| 2005 | 19.35 Million EUR | 16.52% |
| 2004 | 16.61 Million EUR | -66.24% |
| 2003 | 49.2 Million EUR | -72.84% |
| 2002 | 181.14 Million EUR | -19.41% |
| 2001 | 224.78 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 7.19 Million EUR | 0.0% |
| 2023 FY | 7.11 Million EUR | -33.18% |
| 2023 Q2 | 10.74 Million EUR | 0.0% |
| 2023 Q4 | 7.11 Million EUR | 0.0% |
| 2022 FY | 10.64 Million EUR | -64.44% |
| 2022 Q2 | 26.93 Million EUR | 0.0% |
| 2022 Q4 | 10.64 Million EUR | 0.0% |
| 2021 Q4 | 29.93 Million EUR | 0.0% |
| 2021 Q2 | 36.67 Million EUR | 0.0% |
| 2021 FY | 29.93 Million EUR | -27.29% |
| 2020 Q4 | 41.17 Million EUR | 0.0% |
| 2020 FY | 41.17 Million EUR | 25.32% |
| 2020 Q2 | 47.36 Million EUR | 0.0% |
| 2019 Q2 | 27.24 Million EUR | 0.0% |
| 2019 FY | 32.85 Million EUR | 8.11% |
| 2019 Q4 | 32.85 Million EUR | 0.0% |
| 2018 Q2 | 31.39 Million EUR | 0.0% |
| 2018 FY | 30.39 Million EUR | 57.58% |
| 2018 Q4 | 30.39 Million EUR | 0.0% |
| 2017 Q4 | 19.28 Million EUR | 0.0% |
| 2017 FY | 19.28 Million EUR | -30.5% |
| 2017 Q2 | 26.75 Million EUR | 0.0% |
| 2016 Q2 | 28.75 Million EUR | 0.0% |
| 2016 FY | 27.75 Million EUR | 85.0% |
| 2016 Q4 | 27.75 Million EUR | 0.0% |
| 2015 FY | 15 Million EUR | -42.86% |
| 2015 Q2 | 23.75 Million EUR | 0.0% |
| 2015 Q4 | 15 Million EUR | 0.0% |
| 2014 FY | 26.25 Million EUR | -36.36% |
| 2014 Q4 | 26.25 Million EUR | 0.0% |
| 2014 Q2 | 29.36 Million EUR | 0.0% |
| 2013 Q2 | 41.15 Million EUR | 0.0% |
| 2013 Q4 | 41.87 Million EUR | 0.0% |
| 2013 FY | 41.25 Million EUR | 12.05% |
| 2012 Q2 | 69.95 Million EUR | 0.0% |
| 2012 Q4 | 36.81 Million EUR | 0.0% |
| 2012 FY | 36.81 Million EUR | 57.72% |
| 2011 Q4 | 23.34 Million EUR | 0.0% |
| 2011 FY | 23.34 Million EUR | -42.06% |
| 2011 Q2 | 39.45 Million EUR | 0.0% |
| 2010 Q2 | 32.95 Million EUR | 0.0% |
| 2010 FY | 40.28 Million EUR | 532.25% |
| 2010 Q4 | 40.28 Million EUR | 0.0% |
| 2009 FY | 6.37 Million EUR | -46.39% |
| 2009 Q4 | 6.37 Million EUR | 0.0% |
| 2008 FY | 11.88 Million EUR | -33.43% |
| 2007 FY | 17.85 Million EUR | -1.66% |
| 2006 FY | 18.15 Million EUR | -6.2% |
| 2005 FY | 19.35 Million EUR | 16.52% |
| 2004 FY | 16.61 Million EUR | -66.24% |
| 2003 FY | 49.2 Million EUR | -72.84% |
| 2002 FY | 181.14 Million EUR | -19.41% |
| 2001 FY | 224.78 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Affluent Medical SA | 14.41 Million EUR | 50.635% |
| Bluelinea Société Anonyme | 2.11 Million EUR | -237.051% |
| Carmat SA | 57.64 Million EUR | 87.66% |
| Diagnostic Medical Systems S.A. | 13.19 Million EUR | 46.098% |
| Euromedis Groupe | 5.08 Million EUR | -39.872% |
| Eurobio Scientific Société anonyme | 81.23 Million EUR | 91.242% |
| Ikonisys S.A. | 3.2 Million EUR | -121.793% |
| Implanet S.A. | 1.38 Million EUR | -414.761% |
| Median Technologies SA | 21.64 Million EUR | 67.126% |
| SpineGuard SA | 1.87 Million EUR | -279.28% |
| Theraclion SA | 1.95 Million EUR | -264.683% |
| Euroapi S.A. | 15.5 Million EUR | 54.103% |
| Guerbet SA | 360.51 Million EUR | 98.027% |
| Koninklijke Philips N.V. | 6.17 Billion EUR | 99.885% |
| Sequana Medical NV | 8.96 Million EUR | 20.679% |